Bausch Health Companies reported $1.31B in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Amgen USD 5.8B 1.25B Sep/2026
ANI Pharmaceuticals USD 83.3M 11.7M Sep/2026
Aurora Cannabis CAD 799K 2.9M Jun/2026
Bausch Health Companies USD 1.31B 230M Sep/2026
Biogen USD 450.8M 198.9M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Canopy Growth CAD 8M 145M Jun/2026
Corcept Therapeutics USD 115.75M 73.59M Sep/2026
Danaher USD 2.1B 257M Sep/2026
Drreddys Laboratories INR 18.79B 10.16B Sep/2026
Eli Lilly USD 9.46B 3.54B Sep/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
Nektar Therapeutics USD -38.9M 7.09M Mar/2026
Novo Nordisk DKK 37.36B 2.64B Jun/2026
Perrigo USD 156.6M 83M Sep/2026
Phibro Animal Health USD 68.1M 6.2M Dec/2025
Prestige Brands USD 89.44M 28.2M Sep/2026
Supernus Pharmaceuticals USD 55.6M 24M Sep/2026
Vertex Pharmaceuticals USD 888.6M 436.6M Sep/2026
Zoetis USD 1.07B 21M Sep/2026